June 13, 2017
The University of Kansas Medical Center, in consultation with The University of Kansas Health System and The University of Kansas Physicians, announced that Robert D. Simari, M.D., the Franklin E. Murphy Professor in Cardiology, will serve as interim executive vice chancellor for the University of Kansas Medical Center. Simari will assume the interim EVC role July 1 and will continue as executive dean for the University of Kansas School of Medicine.
"Dr. Simari's appointment to this role will provide stability to the medical center campus during this time of transition," said Douglas Girod, M.D., executive vice chancellor for KU Medical Center and incoming chancellor of the University of Kansas. "His leadership in this role will allow KU Medical Center initiatives and programs to continue moving forward without interruption."
A 1986 alumnus of the KU School of Medicine, Simari has served as executive dean since March 2014. He currently serves as the chief academic and administrative officer for the School of Medicine and provides oversight and leadership to all three medical school campuses: Kansas City, Wichita and Salina.
Most recently, he has been instrumental in guiding the School of Medicine's new curriculum development and the construction of the Health Education Building, both of which debut later this summer.
"I am honored to serve as interim executive vice chancellor of KU Medical Center," said Simari. "It is an honor to work with Dr. Girod who is a model of servant leadership. His vision has transformed our campus and my main goal is to maintain the momentum that he has established."
Prior to joining KU, Simari served as vice chair for the Division of Cardiovascular Diseases and co-principal investigator of the Center for Translational Science Activities at the Mayo Clinic in Rochester, Minn., where he also served as a physician scientist, cardiologist and professor of medicine at the Mayo Clinic College of Medicine.
While at the Mayo Clinic, his research laboratory made fundamental discoveries in the areas of thrombosis and identification of vascular stem cells, and for 10 years he led the National Heart, Blood and Lung Institute-funded Cardiovascular Cell Therapy Research Network, which performs early phase clinical trials in cardiovascular cell therapy. In addition, he continues his cardiology practice at The University of Kansas Health System.
Simari earned his bachelor's degree from the University of Notre Dame, and his medical degree from the University of Kansas. Following medical school, he completed his residency at Beth Israel Hospital in Boston, then served fellowships in cardiovascular disease and interventional cardiology at the Mayo Clinic. Following his clinical training he was a postdoctoral research fellow at the University of Michigan.